REGN

Regeneron Pharmaceuticals, Inc. Press Releases

$374.9
*  
9.62
2.5%
Get REGN Alerts
*Delayed - data as of May 3, 2016 11:10 ET  -  Find a broker to begin trading REGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    REGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Regeneron Announces Positive Topline Results from Phase 2/3 Fasinumab Study in Patients with Osteoarthritis Pain
5/2/2016 7:00:00 AM - PR Newswire
▼-0.48 % Price Change since this news event. The Volume Ratio is 1.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Regeneron Announces Upcoming 2016 Investor Conference Presentations
4/29/2016 9:30:00 AM - PR Newswire
▼-4.44 % Price Change since this news event. The Volume Ratio is 1.27.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Regeneron to Report First Quarter 2016 Financial and Operating Results and Host Conference Call and Webcast on May 5, 2016
4/15/2016 9:30:00 AM - PR Newswire
▼-8.31 % Price Change since this news event. The Volume Ratio is 0.5.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Regeneron and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics
4/11/2016 4:05:00 PM - PR Newswire
▼-5.36 % Price Change since this news event. The Volume Ratio is 1.16.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
4/1/2016 1:00:00 AM - PR Newswire
▲4.01 % Price Change since this news event. The Volume Ratio is 5.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
3/24/2016 8:00:00 AM - PR Newswire
▲2.99 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Praluent® (alirocumab) Study in Patients Undergoing LDL Apheresis Therapy
3/23/2016 2:00:00 AM - PR Newswire
▼-0.69 % Price Change since this news event. The Volume Ratio is 0.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Regeneron and Sanofi Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal
3/16/2016 12:30:00 PM - PR Newswire
▼-0.48 % Price Change since this news event. The Volume Ratio is 1.53.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
3/11/2016 1:00:00 AM - PR Newswire
▼-0.70 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Regeneron Genetics Center Publication in New England Journal of Medicine Links ANGPTL4 Inhibition and Risk of Coronary Artery Disease
3/2/2016 5:00:00 PM - PR Newswire
▼-8.07 % Price Change since this news event. The Volume Ratio is 1.1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Regeneron Announces Upcoming 2016 Investor Conference Presentation
2/29/2016 9:30:00 AM - PR Newswire
▼-5.48 % Price Change since this news event. The Volume Ratio is 1.25.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Regeneron Reports Fourth Quarter and Full Year 2015 Financial and Operating Results
2/9/2016 6:30:00 AM - PR Newswire
▼-1.47 % Price Change since this news event. The Volume Ratio is 2.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day